These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17017544)

  • 41. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
    Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.
    Zádori D; Klivényi P; Vámos E; Fülöp F; Toldi J; Vécsei L
    J Neural Transm (Vienna); 2009 Nov; 116(11):1403-9. PubMed ID: 19618107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hippocampal kynurenines as etiological factors in seizure disorders.
    Schwarcz R; Speciale C; French ED
    Pol J Pharmacol Pharm; 1987; 39(5):485-94. PubMed ID: 2906431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Kynurenines and drug research].
    Tóth F; Fülöp F; Szatmári I; Toldi J; Dékány I; Vécsei L
    Orv Hetil; 2020 Mar; 161(12):443-451. PubMed ID: 32172583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease.
    Chen P; Geng X
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2225800. PubMed ID: 37381707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome.
    Li P; Zheng J; Bai Y; Wang D; Cui Z; Li Y; Zhang J; Wang Y
    Eur J Histochem; 2020 Jun; 64(s2):. PubMed ID: 32705857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease.
    Hartai Z; Klivenyi P; Janaky T; Penke B; Dux L; Vecsei L
    J Neurol Sci; 2005 Dec; 239(1):31-5. PubMed ID: 16099471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.
    Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Pessoa-Pureur R; Wyse ATS
    Mol Neurobiol; 2018 Jun; 55(6):5111-5124. PubMed ID: 28840509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease.
    Sharma R; Razdan K; Bansal Y; Kuhad A
    Expert Opin Ther Targets; 2018 Oct; 22(10):849-867. PubMed ID: 30223691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
    Moroni F
    Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep disturbance and kynurenine metabolism in depression.
    Cho HJ; Savitz J; Dantzer R; Teague TK; Drevets WC; Irwin MR
    J Psychosom Res; 2017 Aug; 99():1-7. PubMed ID: 28712413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.
    Zádori D; Veres G; Szalárdy L; Klivényi P; Vécsei L
    J Alzheimers Dis; 2018; 62(2):523-547. PubMed ID: 29480191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
    Majerova P; Olesova D; Golisova G; Buralova M; Michalicova A; Vegh J; Piestansky J; Bhide M; Hanes J; Kovac A
    Biomed Pharmacother; 2022 Aug; 152():113257. PubMed ID: 35714514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.